Found: 10
Select item for more details and to access through your institution.
Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage.
- Published in:
- Inflammation, 2021, v. 44, n. 2, p. 518, doi. 10.1007/s10753-020-01348-0
- By:
- Publication type:
- Article
Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells.
- Published in:
- Journal of Digestive Diseases, 2013, v. 14, n. 2, p. 84, doi. 10.1111/1751-2980.12003
- By:
- Publication type:
- Article
A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection.
- Published in:
- Journal of Food Science & Technology, 2017, v. 54, n. 5, p. 1184, doi. 10.1007/s13197-017-2520-0
- By:
- Publication type:
- Article
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02242-9
- By:
- Publication type:
- Article
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH.
- Published in:
- Journal of Inflammation Research, 2012, v. 5, p. 141, doi. 10.2147/JIR.S35227
- By:
- Publication type:
- Article
Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1242551
- By:
- Publication type:
- Article
Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.718191
- By:
- Publication type:
- Article
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.
- Published in:
- Journal of Clinical Immunology, 2015, v. 35, n. 4, p. 399, doi. 10.1007/s10875-015-0160-6
- By:
- Publication type:
- Article
Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID‐19.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 615, doi. 10.1002/ddr.21890
- By:
- Publication type:
- Article